Primary de‐differentiated, trans‐differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum

• Published in: Histopathology Vol. 80; no. 1; pp. 135 - 149
• Main Authors: Ferreira, Ingrid, Arends, Mark J, Weyden, Louise, Adams, David J, Brenn, Thomas
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01-01-2022
• Subjects: atypical fibroxanthoma; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Cell Dedifferentiation - physiology; Cell Differentiation - physiology; de‐differentiated; Diagnosis; Head and neck; Humans; Literature reviews; Melanoma; Melanoma - genetics; Melanoma - metabolism; Melanoma - pathology; Mucosa; Mutation; Phenotypes; pleomorphic dermal sarcoma; Point mutation; rhabdomyosarcoma; Skin - metabolism; Skin - pathology; Skin Neoplasms - genetics; Skin Neoplasms - metabolism; Skin Neoplasms - pathology; Sox10 protein; Tumors; undifferentiated; de-differentiated; melanoma; undifferentiated; rhabdomyosarcoma; pleomorphic dermal sarcoma; atypical fibroxanthoma
• ISSN: 0309-0167; 1365-2559
• DOI: 10.1111/his.14545

Primary cutaneous and mucosal melanoma shows a wide histological spectrum. The correct diagnosis depends upon the demonstration of melanocytic differentiation by recognition of an associated in‐situ component or immunohistochemical evidence of a melanocytic phenotype using conventional melanocytic markers, such as S‐100, SOX10, Melan‐A and HMB‐45. Exceptionally, melanomas lose their melanocytic phenotype, at least focally, and show differentiation towards other lineages. Review of the literature shows that de‐ and trans‐differentiation in melanoma is rare but probably under‐recognised and under‐reported. These often large and frequently ulcerated tumours affect adults and show a wide anatomical distribution, including mucosal sites, although there is a predilection for sun‐damaged skin of the head and neck. Histologically, the tumours are biphasic and contain a pre‐existing conventional melanoma. The de‐differentiated component closely resembles atypical fibroxanthoma, both morphologically and immunohistochemically. Trans‐differentiated melanoma may show rhabdomyosarcomatous or spindle cell carcinomatous features. Undifferentiated melanomas are similar tumours in which the conventional melanoma component is absent. Their diagnosis depends entirely upon the clinical context and identification of a classical melanoma driver gene mutation, i.e. BRAF V600E. The diagnosis of these rare and unusual tumours is challenging, and requires thorough tumour sampling and recognition of the background of a pre‐existing but often focal conventional melanoma together with molecular analysis.